INDICATORS ON CLINICAL TRIAL RECRUITMENT FOR ABBV-744 STUDY YOU SHOULD KNOW

In Section A, individuals will receive distinctive doses and schedules of oral ABBV-744 tablet to recognize Protected dosing program. Supplemental members is going to be enrolled on the determined monotherapy dosign regimen. In Section B, individuals will acquire oral ruxolitinib and ABBV-744 might be presented as "include-on" therapy. In Phase C,